Navigation Links
Generics and Biosimilars in Central and Eastern Europe 25-26 June - Warsaw, Poland
Date:4/4/2013

LONDON, April 4, 2013 /PRNewswire/ --

Having shown steady recovery from the global economic crisis, the CEE region continues to gain investment from foreign market players, quite a few of which have already successfully established their business in the region. Local market players like Polpharma, Gedeon Richter , Krka, Zentiva and Lek (recently acquired by the Novartis Group), have an impressively strong position within the entire CEE region, becoming a growing subject of interest for the Multinationals and their portfolio ambitions.

With this in mind, CPhI Conferences, in partnership with Polpharma, is proud to present its inaugural conference on Generics and Biosimilars in Central and Eastern Europe which has been designed to assess regulatory hurdles, share best practice and highlight ample market opportunities.

We are delighted to be joined by high-quality industry professionals including IMS Health, MHRA, Janssen Pharmaceuticals, Egis, Polpharma, Selvita and many more. With expert speakers in generic and biosimilar development across the merging markets of CEE, this conference offers the opportunity to network and debate with leaders in this field.

Over the course of two intensive days there will be practical and informative sessions on the current and future market trends, innovation strategies in generic and biosimilar development, identifying the crucial factors in successful partnerships, commercialisation and market access. This is an essential opportunity to gather the information you need to advance your business strategy and establish yourself in this lucrative market.


For the full programme including a list of the expert speakers and to register please visit http://www.cphi-cee.com

About CPhI Conferences:

CPhI Conferences deliver the latest pharma market insight, in-depth case studies and exceptional networking opportunities through a programme of high-level conferences. The worldwide series of events, spanning four continents, provides the optimum forum for you to learn, make new business connections and identify the latest growth opportunities. Delivered by expert teams in each region, every conference is extensively researched with leading professionals, ensuring that CPhI Conferences tackle the most business critical issues facing the pharma industry today.

http://www.cphiconferences.com

For further information, please contact:

Svetlana Fathers
Senior Conference Producer
CPhI Conferences
Tel: +44(0)20-7955-3973
E-mail: svetlana.fathers@ubm.com


'/>"/>
SOURCE CPhI Conferences
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Managing Bioequivalence Studies to Optimize Cost, Quality, and Outsourcing of Generics Manufacturing
2. Active Pharmaceutical Ingredients (API) Market in the Americas to 2017 - Shift Towards Generics and Biosimilars as South and Central America Emerges as a Key Growth Region
3. Watson Announces Global Generics Management Team
4. Generics Analysis: Key Patent Case Reviews
5. Branded Generics in South East Asia: Current and Future Opportunities
6. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
7. Generics in the Antivirals Market to 2018 - Launch of Generic Combivir and Patent Expiry of Sustiva, Kaletra and Epivir-HBV will Drive Volume Growth
8. Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
9. Lupus Foundation of Florida Applauds Support for Biosimilars Legislation
10. Two New Strategic Reports Expand Coverage Of BioTrends Biosimilars Advisory Service
11. Global Biosimilars Market - Products, Applications and Regulations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2017)... Tenn. , July 31, 2017 Three Tru-D SmartUVC ... Yongsan, South Korea . Tru-D, short for "Total Room ... and operating rooms after an environmental services (ES) professional cleans the area ... ... "Although the ...
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... WARSAW, Ind., July 27, 2017  Zimmer Biomet Holdings, ... the quarter ended June 30, 2017.  The Company reported ... of 1.1% over the prior year period, and an ... approximately 240 basis points of contribution from the LDR ... from the second quarter of 2016, or 0.3% on ...
Breaking Medicine Technology:
(Date:8/16/2017)... California (PRWEB) , ... August 16, 2017 , ... An August 3rd article ... was the subject of a report in JAMA (the Journal of the American Medical Association). ... 50 were able to achieve BMIs under 30, when compared to patients with lower BMIs. ...
(Date:8/16/2017)... ... 16, 2017 , ... For the second year, the Brain ... educate the public on the impact of concussions. Brooke Mills, student and founder ... Awareness Day. , Brooke is working diligently is to raise awareness of concussion ...
(Date:8/16/2017)... Island, NY (PRWEB) , ... August 16, 2017 , ... ... with IV starts and blood draws. By broadly deploying AccuVein devices, Maury Regional Medical ... takes much of the guesswork out of a needle stick and more importantly, helps ...
(Date:8/16/2017)... YORK, NY (PRWEB) , ... August 16, 2017 , ... ... for better treatments and ultimately, a cure. , The grants are awarded through ... comprised of scientists with a wide array of backgrounds and expertise in all areas ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... eBook, 9781498499620    ) shares that during the time of a cancer diagnosis, surgery and ... God's love, and all the many ways God shows love to those who ...
Breaking Medicine News(10 mins):